NCT03254043View on ClinicalTrials.gov

Evaluating a Novel Medication Device for Methadone Dosing

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

Take-home Dosing Procedures

Within-subject evaluation across 2 phases with a final choice condition

Trial Locations (1)

21224

Addiction Treatment Services (ATS), Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT03254043 - Evaluating a Novel Medication Device for Methadone Dosing | Biotech Hunter | Biotech Hunter